Finance

Lists
PHM:BME
Pharma Mar SA
€ ६८.६०
-१.६५%
(-१.१५) 1D
अक्टोबर ८, १७:३५:२७ GMT+२  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for PHM...
Open
€ ६९.५५
High
€ ६९.५५
Low
€ ६८.०५
Mkt. cap
१.२६ अरब
Avg. vol.
२९.११ हजार
Volume
३२.३४ हजार
Dividend
१.४६%
Quarterly dividend
€ ०.२५
Ex-dividend date
२०२३ जुन ७
P/E ratio
२०.८८
52-wk high
€ १०५.२०
52-wk low
€ ६४.००
EPS
€ ३.२९
Shares outstanding
१.८० करोड
No. of employees
५०५
Open
€ ६९.५५
High
€ ६९.५५
Low
€ ६८.०५
Mkt. cap
१.२६ अरब
Avg. vol.
२९.११ हजार
Volume
३२.३४ हजार
Dividend
१.४६%
Quarterly dividend
€ ०.२५
Ex-dividend date
२०२३ जुन ७
P/E ratio
२०.८८
52-wk high
€ १०५.२०
52-wk low
€ ६४.००
EPS
€ ३.२९
Shares outstanding
१.८० करोड
No. of employees
५०५
News stories
From web sources and news partners
www.marketscreener.com
www.marketscreener.com
·
१६ मिनेट पहिले
Wah Fu Announces Corporate Name Change to Wah Fu Education & Technology Group Limited and Nasdaq Ticker “WAFU” Unchanged
The Hollywood Reporter
The Hollywood Reporter
·
५४ मिनेट पहिले
On the Floor as Skydance Tries to Win Over Wall Street
Simply Wall Street
Simply Wall Street
·
१३ मिनेट पहिले
CEO Change Could Be A Game Changer For Adeia (ADEA)
Yahoo Finance
Yahoo Finance
·
१ घण्टा पहिले
Q2 Earnings Highs And Lows: Clarus (NASDAQ:CLAR) Vs The Rest Of The Consumer Discretionary - Leisure Products Stocks
About Pharma Mar SA
CEO-
Employees५०५
Founded१९८६
Headquarters-
Sector-
Websitepharmamar.com
Last report
२०२६ जुलाई ३०
Fiscal period
Q2 2026
€ ०.०२ / € ०.१८
-९०.९९%miss
Revenue / Est. (EUR)
९.२५ करोड / ४.५२ करोड
+१०४.५५%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in EUR
Loading Previous Earnings...
Revenue
Net income
All values in EUR
२०२५ सेप्टेम्बर
२०२५ डिसेम्बर
२०२६ मार्च
२०२६ जुन
Revenue
३.५७ करोड
९.०५ करोड
४.२९ करोड
४.९६ करोड
Cost of goods sold
२३.०४ लाख
३७.७४ लाख
३६.५८ लाख
४७.३४ लाख
Cost of revenue
२३.०४ लाख
३७.७४ लाख
३६.५८ लाख
४७.३४ लाख
Research and development expenses
२.२१ करोड
२.५६ करोड
२.०९ करोड
२.६४ करोड
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
६६.३० लाख
१.७३ करोड
१.५३ करोड
१.७१ करोड
Operating expense
३.७३ करोड
४.३१ करोड
३.८६ करोड
४.६३ करोड
Total operating expenses
३.९६ करोड
४.६९ करोड
४.२३ करोड
५.१० करोड
Operating income
-३९.५९ लाख
४.३६ करोड
६.२२ लाख
-१४.०५ लाख
Other non operating income
-
-
-
-
EBT including unusual items
-४०.७६ लाख
४.४३ करोड
१५.९८ लाख
-९.९३ लाख
EBT excluding unusual items
-४०.७६ लाख
४.४३ करोड
१५.९८ लाख
-९.९३ लाख
Income tax expense
२४.०० हजार
-१.५४ करोड
६५.०० हजार
-२१.०० हजार
Effective tax rate
-०.५९%
-३४.७५%
४.०७%
२.११%
Other operating expenses
८५.६१ लाख
१.९५ लाख
२४.३२ लाख
२७.७३ लाख
Net income
-४१.०० लाख
५.९७ करोड
१५.३३ लाख
-९.७२ लाख
Net profit margin
-११.५०%
६५.९५%
३.५७%
-१.९६%
Earnings per share
-
-
-
-
Interest and investment income
-
३४.४३ लाख
९.७६ लाख
४.१२ लाख
Interest expense
-१.१७ लाख
-७.२४ लाख
-
-
Net interest expenses
-१.१७ लाख
२७.१९ लाख
९.७६ लाख
४.१२ लाख
Depreciation and amortization charges
-
-
-
-
EBITDA
-१९.४९ लाख
४.५६ करोड
२७.०७ लाख
७.०० लाख
Gain or loss from assets sale
-१०.०० हजार
-७.५४ लाख
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google एपहरू